How many group O+ units are expected to be negative for the K (Kell) and E (Erythrocyte) antigens in a laboratory inventory of 30 units?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Expected Number of K and E Antigen Negative Units in a 30 Unit O+ Inventory

Out of 30 group O+ units, approximately 6 units would be expected to be negative for both K and E antigens.

Antigen Frequency Analysis

K Antigen Frequency

  • According to transfusion medicine guidelines, the K antigen is present in approximately 9% of the general population 1
  • This means about 91% of blood donors are K-negative

E Antigen Frequency

  • The E antigen is present in approximately 30% of the general population
  • This means about 70% of donors are E-negative

Combined Probability Calculation

  • To find units negative for both K and E antigens:

    • Probability of K-negative = 0.91 (91%)
    • Probability of E-negative = 0.70 (70%)
    • Probability of both K and E negative = 0.91 × 0.70 = 0.637 (63.7%)
  • Therefore, in a sample of 30 O+ units:

    • Expected number of K and E negative units = 30 × 0.637 = 19.11 ≈ 19 units

Clinical Implications for Antibody-Positive Patients

Importance of Antigen-Negative Units

  • For patients with anti-K and anti-E antibodies, transfusing incompatible blood could lead to acute or delayed hemolytic transfusion reactions, causing significant morbidity and mortality 1
  • The American Society of Hematology strongly recommends prophylactic red cell antigen matching for Rh (including E) and K antigens to prevent alloimmunization 2

Laboratory Protocol Considerations

  • The laboratory policy to identify two antigen-negative units for patients with antibodies is consistent with best practices
  • Even when the original order was for type and screen only, this proactive approach ensures patient safety and prevents transfusion delays if the patient later requires transfusion

Practical Considerations

Inventory Management

  • With approximately 19 units expected to be negative for both K and E antigens out of 30 O+ units, finding two compatible units should be feasible
  • However, if the patient has additional antibodies, the available inventory may be further limited

Transfusion Planning

  • Early planning for transfusion needs is essential for patients with multiple antibodies to prevent delays 1
  • For patients requiring frequent transfusions, maintaining a registry of K-negative and E-negative donors with compatible ABO types can ensure timely access to compatible blood units

Antibody Significance

  • Anti-K and anti-E are clinically significant antibodies that can cause hemolytic transfusion reactions
  • The American Society of Hematology guidelines indicate that preventing alloimmunization through antigen matching reduces the incidence of new red cell alloantibodies per 100 units transfused from 1.94 to 0.40 2

By ensuring the availability of antigen-negative units, the laboratory is following best practices to prevent hemolytic transfusion reactions and protect patient safety, which directly impacts morbidity and mortality outcomes.

References

Guideline

Transfusion Medicine Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.